Related Experiment Video
Updated: Oct 7, 2025
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.2K
Occam's Razor and Managing Acute Thrombosis in the COVID-19 Era.
Thomas Lovelock1,2, Stuart R Walker1,2, Catherine Thoo1
1Department of Vascular Surgery, 34379Royal Hobart Hospital, Hobart, Tas, Australia.
Vascular and Endovascular Surgery
|January 10, 2022
Summary
Thrombosis with thrombocytopaenia syndrome (VITTS) is a rare complication of COVID-19 vaccination. While important to recognize, excessive focus on VITTS may divert attention from more common causes of acute thrombosis in vaccinated patients.
Area of Science:
- Medical Research
- Clinical Medicine
- Immunology
Background:
- The COVID-19 pandemic has significantly altered medical practice in Australia.
- Vaccine development for COVID-19 has introduced rare adverse events, including vaccine-induced immune thrombotic thrombocytopenia (VITT).
Purpose of the Study:
- To discuss the rare syndrome of thrombosis and thrombocytopaenia (VITTS) associated with COVID-19 vaccines.
- To highlight the importance of considering common causes of acute thrombosis despite the emergence of rare vaccine-associated syndromes.
Main Methods:
- Case review and discussion.
- Analysis of clinical presentation and diagnostic considerations for thrombosis.
Main Results:
- Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare but recognized complication of COVID-19 vaccination.
- The prevalence of VITT is low, and overemphasis on its diagnosis may obscure more frequent causes of acute thrombosis.
Conclusions:
- Clinicians managing acute thrombosis should be aware of VITT, especially in recently vaccinated individuals.
- It is crucial to maintain a broad differential diagnosis for acute thrombosis, avoiding diagnostic overshadowing by rare vaccine-associated conditions.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
51
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
51
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.4K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.4K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.0K
01:30Venous Thrombosis IV: Nursing Management
43
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
43
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
64
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
64
01:16Clot Retraction and Fibrinolysis
7.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
7.3K